|
1
|
Mizutani M, Kern TS and Lorenzi M:
Accelerated death of retinal microvascular cells in human and
experimental diabetic retinopathy. J Clin Invest. 97:2883–2890.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Asnaghi V, Gerhardinger C, Hoehn T,
Adeboje A and Lorenzi M: A role for the polyol pathway in the early
neuroretinal apoptosis and glial changes induced by diabetes in the
rat. Diabetes. 52:506–511. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Barber AJ, Lieth E, Khin SA, Antonetti DA,
Buchanan AG and Gardner TW: Neural apoptosis in the retina during
experimental and human diabetes. Early onset and effect of insulin.
J Clin Invest. 102:783–791. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kern TS and Barber AJ: Retinal ganglion
cells in diabetes. J Physiol. 586:4401–4408. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Brownlee M: Advanced protein glycosylation
in diabetes and aging. Annu Rev Med. 46:223–234. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Koga K, Yamagishi S, Okamoto T, et al:
Serum levels of glucose-derived advanced glycation end products are
associated with the severity of diabetic retinopathy in type 2
diabetic patients without renal dysfunction. Int J Clin Pharmacol
Res. 22:13–17. 2002.PubMed/NCBI
|
|
7
|
Miura J, Yamagishi S, Uchigata Y, et al:
Serum levels of non-carboxymethyllysine advanced glycation
endproducts are correlated to severity of microvascular
complications in patients with Type 1 diabetes. J Diabetes
Complications. 17:16–21. 2003. View Article : Google Scholar
|
|
8
|
Hammes HP, Alt A, Niwa T, et al:
Differential accumulation of advanced glycation end products in the
course of diabetic retinopathy. Diabetologia. 42:728–736. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lecleire-Collet A, Tessier LH, Massin P,
et al: Advanced glycation end products can induce glial reaction
and neuronal degeneration in retinal explants. Br J Ophthalmol.
89:1631–1633. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kasper M, Roehlecke C, Witt M, et al:
Induction of apoptosis by glyoxal in human embryonic lung
epithelial cell line L132. Am J Respir Cell Mol Biol. 23:485–491.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kaji Y, Amano S, Usui T, et al: Expression
and function of receptors for advanced glycation end products in
bovine corneal endothelial cells. Invest Ophthalmol Vis Sci.
44:521–528. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yamagishi S, Inagaki Y, Amano S, Okamoto
T, Takeuchi M and Makita Z: Pigment epithelium-derived factor
protects cultured retinal pericytes from advanced glycation end
product-induced injury through its antioxidative properties.
Biochem Biophys Res Commun. 296:877–882. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Deane R, Du Yan S, Submamaryan RK, et al:
RAGE mediates amyloid-beta peptide transport across the blood-brain
barrier and accumulation in brain. Nat Med. 9:907–913. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hammes HP, Martin S, Federlin K, Geisen K
and Brownlee M: Aminoguanidine treatment inhibits the development
of experimental diabetic retinopathy. Proc Natl Acad Sci USA.
88:11555–11558. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kern TS and Engerman RL: Pharmacological
inhibition of diabetic retinopathy: aminoguanidine and aspirin.
Diabetes. 50:1636–1642. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kern TS, Tang J, Mizutani M, et al:
Response of capillary cell death to aminoguanidine predicts the
development of retinopathy: comparison of diabetes and
galactosemia. Invest Ophthalmol Vis Sci. 41:3972–3978.
2000.PubMed/NCBI
|
|
17
|
Vasan S, Foiles PG and Founds HW:
Therapeutic potential of AGE inhibitors and breakers of AGE protein
cross-links. Expert Opin Investig Drugs. 10:1977–1987. 2001.
View Article : Google Scholar
|
|
18
|
Harris CS, Beaulieu LP, Fraser MH, et al:
Inhibition of advanced glycation end product formation by medicinal
plant extracts correlates with phenolic metabolites and antioxidant
activity. Planta Med. 77:196–204. 2011. View Article : Google Scholar
|
|
19
|
Lee SY, Min BS, Kim JH, et al: Flavonoids
from the leaves of Litsea japonica and their anti-complement
activity. Phytother Res. 19:273–276. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Min BS, Lee SY, Kim JH, et al: Lactones
from the leaves of Litsea japonica and their anti-complement
activity. J Nat Prod. 66:1388–1390. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sohn EJ, Kim J, Kim CS, et al: The extract
of Litsea japonica reduced the development of diabetic nephropathy
via the inhibition of advanced Glycation end products accumulation
in db/db mice. Evid-Based Compl Alt Med. 2013:7694162013.
|
|
22
|
Sohn EJ, Kim CS, Kim YS, et al: Effects of
magnolol (5,5′-diallyl-2,2′-dihydroxybiphenyl) on diabetic
nephropathy in type 2 diabetic Goto-Kakizaki rats. Life Sci.
80:468–475. 2007. View Article : Google Scholar
|
|
23
|
Hernández-Presa MA, Gómez-Guerrero C and
Egido J: In situ non-radioactive detection of nuclear factors in
paraffin sections by Southwestern histochemistry. Kidney Int.
55:209–214. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yamagishi S, Takeuchi M, Matsui T,
Nakamura K, Imaizumi T and Inoue H: Angiotensin II augments
advanced glycation end product-induced pericyte apoptosis through
RAGE overexpression. FEBS Lett. 579:4265–4270. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Romeo G, Liu WH, Asnaghi V, Kern TS and
Lorenzi M: Activation of nuclear factor-kappaB induced by diabetes
and high glucose regulates a proapoptotic program in retinal
pericytes. Diabetes. 51:2241–2248. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kowluru RA, Koppolu P, Chakrabarti S and
Chen S: Diabetes-induced activation of nuclear transcriptional
factor in the retina and its inhibition by antioxidants. Free Radic
Res. 37:1169–1180. 2003. View Article : Google Scholar
|
|
27
|
Hammes HP, Federoff HJ and Brownlee M:
Nerve growth factor prevents both neuroretinal programmed cell
death and capillary pathology in experimental diabetes. Mol Med.
1:527–534. 1995.PubMed/NCBI
|
|
28
|
Kerrigan LA, Zack DJ, Quigley HA, Smith SD
and Pease ME: TUNEL-positive ganglion cells in human primary
open-angle glaucoma. Arch Ophthalmol. 115:1031–1035. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chiarelli F, Catino M, Tumini S, et al:
Advanced glycation end products in adolescents and young adults
with diabetic angiopathy. Pediatr Nephrol. 14:841–846. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ono Y, Aoki S, Ohnishi K, Yasuda T, Kawano
K and Tsukada Y: Increased serum levels of advanced glycation
end-products and diabetic complications. Diabetes Res Clin Pract.
41:131–137. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Funk RH and Schmidt KG: Characteristic
features of optic nerve ganglion cells and approaches for
neuroprotection. From intracellular to capillary processes and
therapeutic considerations. Ophthalmologe. 101:1062–1070. 2004.In
German. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yamagishi S, Hsu CC, Taniguchi M, et al:
Receptor-mediated toxicity to pericytes of advanced glycosylation
end products: a possible mechanism of pericyte loss in diabetic
microangiopathy. Biochem Biophys Res Commun. 213:681–687. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yamagishi S, Amano S, Inagaki Y, et al:
Advanced glycation end products-induced apoptosis and
overexpression of vascular endothelial growth factor in bovine
retinal pericytes. Biochem Biophys Res Commun. 290:973–978. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yamagishi S, Nakamura K and Matsui T:
Advanced glycation end products (AGEs) and their receptor (RAGE)
system in diabetic retinopathy. Curr Drug Discov Technol. 3:83–88.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lee EH, Song DG, Lee JY, Pan CH, Um BH and
Jung SH: Flavonoids from the leaves of Thuja orientalis inhibit the
aldose reductase and the formation of advanced glycation
endproducts. J Korean Soc Appl Biol Chem. 52:448–455. 2009.
View Article : Google Scholar
|
|
36
|
Jang DS, Kim JM, Lee YM, et al: Flavonols
from Houttuynia cordata with protein Glycation and Aldose reductase
inhibitory activity. Nat Prod Sci. 12:210–213. 2006.
|
|
37
|
Matsuda H, Wang T, Managi H and Yoshikawa
M: Structural requirements of flavonoids for inhibition of protein
glycation and radical scavenging activities. Bioorg Med Chem.
11:5317–5323. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kim J, Kim KM, Kim CS, et al: Puerarin
inhibits the retinal pericyte apoptosis induced by advanced
glycation end products in vitro and in vivo by inhibiting NADPH
oxidase-related oxidative stress. Free Radic Biol Med. 53:357–365.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wu T, Chiang SK, Chau FY and Tso MO:
Light-induced photoreceptor degeneration may involve the NF
kappaB/caspase-1 pathway in vivo. Brain Res. 967:19–26. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Choi JS, Kim JA, Kim DH, et al: Failure to
activate NF-kappaB promotes apoptosis of retinal ganglion cells
following optic nerve transection. Brain Res. 883:60–68. 2000.
View Article : Google Scholar : PubMed/NCBI
|
